Medicare Enrolled
Dr. Rami Owera, M.D.
Hematology & Oncology · Pensacola, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Owera from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Owera?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Owera
Dr. Rami Owera is a hematology & oncology specialist in Pensacola, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Owera performed 168,215 Medicare services across 3,832 unique beneficiaries.
Between the years covered by Open Payments, Dr. Owera received a total of $112,610 from 55 pharmaceutical and/or device companies across 404 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Owera is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 3% volume in FL
$112,610 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 103254 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗168,215
Medicare services
Top 3% in FL for hematology & oncology
3,832
Unique beneficiaries
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~8,853 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Pembrolizumab injection (Keytruda) | 26,600 | $43 | $131 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
26,425 | $2 | $21 |
| Filgrastim injection (Nivestym) for white blood cells An injection of the biosimilar medication filgrastim-aafi (Nivestym) at a dose of 1 microgram. |
22,020 | $0 | $2 |
| Azacitidine chemotherapy injection An injection of the medication azacitidine, measured at 1 mg per unit. |
12,600 | $0 | $14 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
11,525 | $0 | $3 |
| Paclitaxel chemotherapy injection | 10,431 | $0 | $1 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
9,470 | $0 | $36 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
8,700 | $0 | $6 |
| Denosumab injection (Prolia/Xgeva) | 7,800 | $18 | $46 |
| Anti-nausea injection (aprepitant) | 7,280 | $1 | $8 |
| Bevacizumab-bvzr biosimilar injection, 10 mg An injection of bevacizumab-bvzr, a biosimilar medication, administered in a 10 mg dose. |
5,230 | $24 | $166 |
| Immune globulin infusion (Octagam) This procedure involves the administration of immune globulin medication directly into a vein. It is provided in a non-lyophilized liquid form. |
2,530 | $34 | $231 |
| Iron infusion (Monoferric) | 2,200 | $16 | $71 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,110 | $0 | $1 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,946 | $94 | $224 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,430 | $1 | $122 |
| Injection, granisetron hydrochloride, 100 mcg | 1,350 | $0 | $25 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
1,310 | $6 | $30 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
702 | $12 | $105 |
| Injection, leucovorin calcium, per 50 mg | 594 | $3 | $27 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
557 | $99 | $686 |
| Gadobenate dimeglumine injection Administration of gadobenate dimeglumine, a contrast agent used to enhance imaging results. |
420 | $1 | $16 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
395 | $2 | $300 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
394 | $2 | $12 |
| Pegfilgrastim-apgf injection An injection of pegfilgrastim-apgf, a biosimilar medication. The dose specified is 0.5 mg. |
360 | $81 | $157 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
357 | $11 | $93 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
218 | $22 | $152 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
217 | $63 | $148 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
203 | $7 | $462 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
192 | $1 | $6 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
173 | $1 | $5 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
156 | $140 | $301 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 151 | $410 | $638 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
148 | $1,203 | $4,120 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
143 | $55 | $205 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
140 | $50 | $334 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
135 | $47 | $304 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
130 | $21 | $156 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
112 | $25 | $141 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
109 | $15 | $97 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
103 | $223 | $1,400 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
98 | $88 | $1,005 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
98 | $125 | $343 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
91 | $5 | $30 |
| Digital breast tomosynthesis (3D mammogram) A specialized imaging test that creates three-dimensional pictures of the breast tissue to help detect abnormalities. |
83 | $40 | $226 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
65 | $4 | $26 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
60 | $1 | $19 |
| Diagnostic mammography of both breasts | 51 | $111 | $536 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
48 | $64 | $157 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
45 | $92 | $861 |
| New patient office visit, complex (60-74 min) | 43 | $160 | $432 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
38 | $43 | $281 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
37 | $15 | $91 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
36 | $133 | $986 |
| Diagnostic mammography of 1 breast An X-ray examination of one breast to evaluate specific breast symptoms or abnormalities. |
34 | $85 | $423 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
34 | $25 | $249 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
30 | $2 | $19 |
| Screening mammography An X-ray of the breast used to detect breast cancer in women who have no signs or symptoms of the disease. |
29 | $125 | $433 |
| 3D screening mammography (tomosynthesis) A screening imaging test of the breast using 3D technology to detect potential abnormalities. |
26 | $52 | $226 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
23 | $15 | $111 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
23 | $106 | $297 |
| MRI of abdomen with and without contrast An MRI scan of the abdomen using contrast dye before and after administration to create detailed images of internal structures. |
19 | $276 | $3,458 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
19 | $37 | $421 |
| MRI of brain with and without contrast An MRI scan of the brain using contrast dye both before and after administration to provide detailed images of brain structures. |
18 | $251 | $3,387 |
| Blood sample collection from implanted device This procedure involves drawing a blood sample directly from a medical device that has been surgically placed in the body. |
17 | $21 | $64 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
17 | $29 | $240 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
16 | $149 | $892 |
| Complete breast ultrasound, 1 breast A complete ultrasound examination of one breast to visualize internal structures. |
15 | $103 | $432 |
| Limited ultrasound of 1 breast A focused ultrasound examination of a single breast to evaluate specific areas of concern. |
13 | $71 | $355 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
12 | $140 | $412 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
11 | $41 | $166 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.6% high complexity
94.6% medium
1.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$112,610
Total received (2018-2024)
Avg $16,087/year across 7 years
Top 9% in FL for hematology & oncology
55
Companies
404
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$82,499 (73.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$26,214 (23.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,897 (3.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$16,459
2023
$24,457
2022
$11,995
2021
$2,637
2020
$9,624
2019
$27,190
2018
$20,248
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
BeiGene USA, Inc.
$30,788
Exelixis Inc.
$24,088
Janssen Biotech, Inc.
$15,003
Pharmacyclics LLC, An AbbVie Company
$9,541
Gilead Sciences, Inc.
$7,910
AstraZeneca Pharmaceuticals LP
$6,568
Kite Pharma, Inc.
$6,285
Ipsen Biopharmaceuticals, Inc
$4,707
Karyopharm Therapeutics Inc.
$1,550
E.R. Squibb & Sons, L.L.C.
$932
Adaptive Biotechnologies Corporation
$855
Novartis Pharmaceuticals Corporation
$852
Astellas Pharma US Inc
$648
BeiGene, Ltd.
$450
Celgene Corporation
$231
PFIZER INC.
$208
Eisai Inc.
$162
Amgen Inc.
$151
Genentech USA, Inc.
$149
GENZYME CORPORATION
$145
Merck Sharp & Dohme LLC
$124
Merck Sharp & Dohme Corporation
$116
Janssen Scientific Affairs, LLC
$111
Lilly USA, LLC
$95
Regeneron Healthcare Solutions, Inc.
$91
Mirati Therapeutics, Inc.
$78
ABBVIE INC.
$74
Takeda Pharmaceuticals U.S.A., Inc.
$65
EISAI INC.
$64
Sumitomo Pharma America, Inc.
$43
AVEO Pharmaceuticals, Inc.
$42
Daiichi Sankyo Inc.
$39
Seagen Inc.
$39
Bayer Healthcare Pharmaceuticals Inc.
$38
CSL Behring
$26
EMD Serono, Inc.
$25
Pharmacosmos Therapeutics Inc.
$24
Stemline Therapeutics Inc.
$21
Tempus AI, Inc
$21
Blueprint Medicines Corporation
$20
Heron Therapeutics, Inc.
$19
Progenics Pharmaceuticals, Inc.
$19
Bayer HealthCare Pharmaceuticals Inc.
$19
Janssen Pharmaceuticals, Inc
$18
Myovant Sciences Inc.
$17
Genmab U.S., Inc.
$17
Lexicon Pharmaceuticals, Inc.
$16
Incyte Corporation
$16
Novocure Inc.
$15
SpringWorks Therapeutics, Inc.
$13
Boehringer Ingelheim Pharmaceuticals, Inc.
$13
Coherus Biosciences Inc.
$13
GlaxoSmithKline, LLC.
$12
Teva Pharmaceuticals USA, Inc.
$12
Epizyme, Inc.,
$12
Top 3 companies account for 62.1% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AYVAKIT · Afstyla · Alecensa · BENDEKA · BLENREP · BOSULIF · BRUKINSA · Balversa · CABLIVI · CABOMETYX · CALQUENCE · CINVANTI · Cabometyx · DARZALEX · DAURISMO · ELITEK · ENHERTU · ERLEADA · Enhertu · Epkinly · Erleada · FOTIVDA · FRUZAQLA · Fabhalta · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Idelvion · Imbruvica · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONOFERRIC · MVASI · NINLARO · Neulasta · Nexavar · Nplate · Nubeqa · OGSIVEO · ONIVYDE · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · Optune · Orserdu · PADCEV · PIQRAY · PLUVICTO · PROMACTA · PYLARIFY · Pomalyst · REBLOZYL · SARCLISA · SCEMBLIX · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · Tecartus · Tecentriq · Trodelvy · Udenyca · VENCLEXTA · VERZENIO · Venclexta · XARELTO · XPOVIO · XT CDX · XTANDI · Xermelo · Xtandi · Yescarta · Zydelig · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (73%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology & oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 9% for hematology & oncology in FL.
Equivalent to $67 per 100 Medicare services performed
Geographic Context
Hematology & oncology specialists within 10 mi
20
Per 100K population
6.2
County median income
$65,715
Nearest hospital
BAPTIST HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Owera is a mixed practice specialist, with above-average Medicare volume (top 3% in FL), with speaking/promotional industry engagement in the top 9% of FL peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Owera experienced with pembrolizumab injection (keytruda)?
Based on Medicare claims data, Dr. Owera performed 26,600 pembrolizumab injection (keytruda) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Owera receive payments from pharmaceutical companies?
Yes. Dr. Owera received a total of $112,610 from 55 companies across 404 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Owera's costs compare to other hematology & oncology specialists in Pensacola?
Dr. Owera's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Owera) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Pensacola
Browse hematology & oncology specialists in Pensacola ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in FL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in FL
Which FL hematology & oncology specialists receive the most from drug and device companies.
By company
BeiGene USA, Inc. Payments to Doctors
See all physicians who received payments from BeiGene USA, Inc.
By company
Exelixis Inc. Payments to Doctors
See all physicians who received payments from Exelixis Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology